Variant report

Variant	rs2298954
Chromosome Location	chr3:50287551-50287552
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:5)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:5 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	REST	chr3:50287348-50287575	H1-hESC	embryonic stem cell:	n/a	chr3:50287494-50287512 chr3:50287453-50287462
2	POLR2A	chr3:50287498-50287809	GM12878	blood:	n/a	n/a
3	POLR2A	chr3:50287074-50287590	GM12892	blood:	n/a	n/a
4	POLR2A	chr3:50287345-50287660	HUVEC	blood vessel:	n/a	n/a
5	POLR2A	chr3:50287113-50288135	GM12878	blood:	n/a	n/a

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:50285794..50287814-chr3:50306650..50309079,2	MCF-7	breast:
2	chr3:50286473..50289840-chr3:50357894..50361890,3	MCF-7	breast:
3	chr3:50284602..50287815-chr3:50290818..50293169,4	K562	blood:
4	chr3:50283737..50287668-chr3:50290117..50294367,4	K562	blood:
5	chr3:50283028..50285015-chr3:50286651..50289261,2	MCF-7	breast:
6	chr3:50279236..50281282-chr3:50285946..50288178,2	MCF-7	breast:
7	chr3:50275603..50278218-chr3:50286370..50288420,2	MCF-7	breast:
8	chr3:50263658..50265512-chr3:50286295..50288716,2	K562	blood:
9	chr3:50272949..50274999-chr3:50285398..50287724,2	MCF-7	breast:

No data

Variant related genes	Relation type
GNAI2	TF binding region
ENSG00000114353	Chromatin interaction
ENSG00000012171	Chromatin interaction
ENSG00000213600	Chromatin interaction
ENSG00000068001	Chromatin interaction

Extended variants
information (count: 145 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:117)

rs_ID	r²[population]
rs1005678	0.81[CHB][hapmap]
rs1034408	1.00[CEU][hapmap]
rs1034409	1.00[CEU][hapmap]
rs11130248	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.81[MEX][hapmap];0.85[ASN][1000 genomes]
rs11916258	0.85[GIH][hapmap];0.85[TSI][hapmap]
rs11928538	0.85[GIH][hapmap]
rs12054403	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.81[MEX][hapmap];0.85[ASN][1000 genomes]
rs12485286	0.80[ASN][1000 genomes]
rs12485390	1.00[CHB][hapmap];0.95[JPT][hapmap];0.96[ASN][1000 genomes]
rs12485909	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.89[ASN][1000 genomes]
rs12487392	0.88[ASN][1000 genomes]
rs12488235	0.87[ASN][1000 genomes]
rs12488302	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.88[ASN][1000 genomes]
rs12490809	0.90[JPT][hapmap]
rs12492683	0.85[ASN][1000 genomes]
rs12492880	0.95[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.89[ASN][1000 genomes]
rs12493693	0.89[ASN][1000 genomes]
rs12494414	0.95[CHB][hapmap];0.93[CHD][hapmap];0.91[JPT][hapmap];0.84[ASN][1000 genomes]
rs12495261	0.85[ASN][1000 genomes]
rs12496815	0.81[ASN][1000 genomes]
rs12497018	0.90[ASN][1000 genomes]
rs12498048	0.99[ASN][1000 genomes]
rs12629572	0.81[CHD][hapmap]
rs12632110	1.00[CHB][hapmap];0.95[CHD][hapmap];0.87[JPT][hapmap];0.85[ASN][1000 genomes]
rs12721544	0.86[ASN][1000 genomes]
rs1894324	0.88[ASW][hapmap];1.00[CEU][hapmap];0.85[GIH][hapmap];0.93[MKK][hapmap];1.00[TSI][hapmap];0.83[YRI][hapmap]
rs1989839	0.81[CHD][hapmap]
rs2006199	0.95[CHB][hapmap];0.93[CHD][hapmap];0.91[JPT][hapmap];0.88[ASN][1000 genomes]
rs2071203	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.81[MEX][hapmap];0.90[ASN][1000 genomes]
rs2071204	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.81[MEX][hapmap];0.88[ASN][1000 genomes]
rs2071205	0.88[ASN][1000 genomes]
rs2071801	0.84[ASN][1000 genomes]
rs2071804	0.90[CHB][hapmap];0.95[JPT][hapmap];0.80[ASN][1000 genomes]
rs2072054	0.81[CHB][hapmap];0.86[CHD][hapmap]
rs2073497	0.85[ASN][1000 genomes]
rs2073499	0.81[CHD][hapmap]
rs2073500	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes]
rs2229647	0.89[ASN][1000 genomes]
rs2233474	0.81[CHD][hapmap]
rs2233476	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.81[MEX][hapmap];0.85[ASN][1000 genomes]
rs2236940	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.86[YRI][hapmap];0.98[ASN][1000 genomes]
rs2236941	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.86[YRI][hapmap];0.99[ASN][1000 genomes]
rs2236943	1.00[ASN][1000 genomes]
rs2236944	1.00[CEU][hapmap];1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.96[MKK][hapmap];1.00[TSI][hapmap];0.81[AFR][1000 genomes];0.99[AMR][1000 genomes];0.97[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs2236946	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.81[MEX][hapmap];0.85[ASN][1000 genomes]
rs2236949	0.88[CHB][hapmap];0.94[JPT][hapmap];0.81[ASN][1000 genomes]
rs2236950	0.83[JPT][hapmap]
rs2236969	1.00[CEU][hapmap]
rs2236972	1.00[CEU][hapmap]
rs2236977	1.00[CEU][hapmap]
rs2236978	1.00[CEU][hapmap]
rs2269430	1.00[CHB][hapmap];0.91[JPT][hapmap];0.87[ASN][1000 genomes]
rs2269432	1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[ASN][1000 genomes]
rs2269569	0.81[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs2282750	0.98[ASN][1000 genomes]
rs2282751	0.81[CHD][hapmap]
rs2282757	1.00[CEU][hapmap]
rs2285043	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes]
rs2285044	1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[ASN][1000 genomes]
rs2298953	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.93[LWK][hapmap];1.00[MEX][hapmap];0.94[MKK][hapmap];1.00[TSI][hapmap];0.93[YRI][hapmap];0.91[AFR][1000 genomes];0.99[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2624839	0.86[CHD][hapmap]
rs3213621	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.86[MEX][hapmap];0.84[ASN][1000 genomes]
rs35455589	1.00[CHB][hapmap];0.95[CHD][hapmap];1.00[JPT][hapmap];0.81[MEX][hapmap];0.85[ASN][1000 genomes]
rs35587949	1.00[CHB][hapmap];0.98[CHD][hapmap];0.95[JPT][hapmap];0.81[MEX][hapmap];0.85[ASN][1000 genomes]
rs3774739	0.85[CHB][hapmap];0.93[CHD][hapmap];0.83[JPT][hapmap]
rs3774752	0.90[CHB][hapmap];0.93[CHD][hapmap];0.82[JPT][hapmap];0.81[ASN][1000 genomes]
rs3774753	1.00[CEU][hapmap];1.00[CHB][hapmap];0.95[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.95[MEX][hapmap];0.88[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs3774754	0.84[ASN][1000 genomes]
rs3774755	1.00[CHB][hapmap];0.95[CHD][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes]
rs4141407	1.00[CHB][hapmap];1.00[JPT][hapmap];0.98[ASN][1000 genomes]
rs4688679	1.00[CHB][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes]
rs4688682	1.00[CHB][hapmap];1.00[CHD][hapmap];0.95[JPT][hapmap];0.99[ASN][1000 genomes]
rs4688683	0.90[ASN][1000 genomes]
rs4688724	1.00[CHB][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes]
rs4688725	0.84[ASN][1000 genomes]
rs4688728	0.84[ASN][1000 genomes]
rs4688732	1.00[CHB][hapmap];0.98[CHD][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes]
rs4688733	0.85[ASN][1000 genomes]
rs4688734	1.00[CHB][hapmap];0.97[CHD][hapmap];1.00[JPT][hapmap];0.88[ASN][1000 genomes]
rs4688736	0.87[ASN][1000 genomes]
rs4688738	0.87[ASN][1000 genomes]
rs4688741	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];1.00[ASN][1000 genomes]
rs4688742	1.00[ASN][1000 genomes]
rs4688744	0.98[ASN][1000 genomes]
rs4688746	0.85[JPT][hapmap];0.85[ASN][1000 genomes]
rs57944420	0.84[ASN][1000 genomes]
rs57978992	0.90[ASN][1000 genomes]
rs58181992	0.85[ASN][1000 genomes]
rs58648044	0.98[ASN][1000 genomes]
rs60276643	0.87[ASN][1000 genomes]
rs6446203	1.00[CEU][hapmap];0.85[GIH][hapmap]
rs6767505	1.00[CEU][hapmap]
rs6770258	1.00[CEU][hapmap]
rs6770669	1.00[CEU][hapmap]
rs6776145	0.81[CHD][hapmap]
rs72932959	0.88[ASN][1000 genomes]
rs72932987	0.85[ASN][1000 genomes]
rs743754	1.00[CEU][hapmap]
rs743755	1.00[CEU][hapmap]
rs7626470	1.00[CEU][hapmap]
rs7634307	1.00[CEU][hapmap]
rs7636862	0.94[ASW][hapmap];1.00[CEU][hapmap];0.85[GIH][hapmap];1.00[TSI][hapmap];0.86[YRI][hapmap]
rs7641224	1.00[CEU][hapmap];0.85[GIH][hapmap];1.00[TSI][hapmap]
rs7645537	1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[JPT][hapmap];0.86[MEX][hapmap];1.00[ASN][1000 genomes]
rs7647409	1.00[CEU][hapmap]
rs886075	1.00[CEU][hapmap];0.85[GIH][hapmap];1.00[TSI][hapmap]
rs9311449	0.83[ASN][1000 genomes]
rs9817768	1.00[CEU][hapmap]
rs9828829	1.00[CEU][hapmap]
rs9830408	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.93[YRI][hapmap];0.90[AFR][1000 genomes];0.99[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs9836046	0.82[AFR][1000 genomes]
rs9837658	1.00[CEU][hapmap]
rs9852677	0.86[CHB][hapmap];0.93[CHD][hapmap];0.95[JPT][hapmap];0.83[LWK][hapmap];0.95[MEX][hapmap];0.89[AMR][1000 genomes];0.86[ASN][1000 genomes]
rs9875873	1.00[CEU][hapmap];0.85[GIH][hapmap];1.00[TSI][hapmap]
rs9882618	0.87[ASN][1000 genomes]
rs9883222	0.84[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];0.95[JPT][hapmap];0.91[LWK][hapmap];1.00[MEX][hapmap];0.94[MKK][hapmap];1.00[TSI][hapmap];0.96[YRI][hapmap];0.90[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs9883635	1.00[CEU][hapmap]

Variant overlapped rSNPs/rCNVs (count:28 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1001775	chr3:50129479-50311666	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
2	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
3	nsv1013949	chr3:50151712-50339163	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
4	nsv590250	chr3:50153356-50332697	Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
5	nsv876769	chr3:50155468-50408398	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
6	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
7	esv1793751	chr3:50157364-50476363	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
8	esv1828162	chr3:50157364-50506151	Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	98 gene(s)	inside rSNPs	diseases
9	nsv590251	chr3:50158774-50337422	Active TSS Strong transcription Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
10	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
11	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
12	nsv523560	chr3:50172397-50339163	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
13	nsv460529	chr3:50178011-50324672	Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
14	nsv460530	chr3:50178011-50324672	Bivalent Enhancer Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
15	nsv590252	chr3:50178011-50324672	Enhancers Bivalent Enhancer Strong transcription Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
16	nsv1002916	chr3:50187646-50311666	Enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
17	nsv536564	chr3:50187646-50311666	Flanking Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
18	nsv1014256	chr3:50187646-50339163	Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
19	nsv536565	chr3:50187646-50339163	Flanking Active TSS Bivalent Enhancer Active TSS Strong transcription Enhancers Weak transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
20	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
21	nsv590253	chr3:50196418-50337422	Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
22	esv2757870	chr3:50198478-50371377	Genic enhancers Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
23	esv2759148	chr3:50198478-50371377	Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
24	nsv834692	chr3:50198485-50393464	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	94 gene(s)	inside rSNPs	diseases
25	nsv590254	chr3:50243510-50388607	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
26	nsv460531	chr3:50247824-50436827	Strong transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
27	nsv590255	chr3:50247824-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
28	nsv876772	chr3:50255305-50436827	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:125 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50276400-50294400	Genic enhancers	Lung	lung
2	chr3:50283400-50293200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr3:50283800-50289000	Weak transcription	H9 Cell Line	embryonic stem cell
4	chr3:50283800-50289400	Enhancers	Left Ventricle	heart
5	chr3:50283800-50294000	Weak transcription	Pancreatic Islets	Pancreatic Islet
6	chr3:50284000-50289000	Enhancers	Brain Cingulate Gyrus	brain
7	chr3:50284000-50289200	Genic enhancers	Fetal Adrenal Gland	Adrenal Gland
8	chr3:50284000-50289400	Genic enhancers	Primary B cells from peripheral blood	blood
9	chr3:50284200-50287800	Enhancers	HMEC	breast
10	chr3:50284200-50287800	Genic enhancers	NHLF	lung
11	chr3:50284200-50288200	Enhancers	Right Ventricle	heart
12	chr3:50284200-50288600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
13	chr3:50284200-50289600	Genic enhancers	Duodenum Smooth Muscle	Duodenum
14	chr3:50284200-50289600	Enhancers	Right Atrium	heart
15	chr3:50284200-50289800	Enhancers	Stomach Mucosa	stomach
16	chr3:50284200-50297000	Genic enhancers	Fetal Muscle Trunk	muscle
17	chr3:50284400-50287800	Genic enhancers	Stomach Smooth Muscle	stomach
18	chr3:50284400-50288200	Genic enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
19	chr3:50284400-50289400	Genic enhancers	Breast Myoepithelial Primary Cells	Breast
20	chr3:50284400-50289400	Genic enhancers	Primary mononuclear cells fromperipheralblood	Blood
21	chr3:50284400-50290800	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
22	chr3:50284400-50292000	Weak transcription	Fetal Brain Male	brain
23	chr3:50284400-50293000	Genic enhancers	Primary T cells fromperipheralblood	blood
24	chr3:50284400-50295000	Genic enhancers	Spleen	Spleen
25	chr3:50284400-50295800	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
26	chr3:50284400-50297000	Genic enhancers	Fetal Muscle Leg	muscle
27	chr3:50284600-50287600	Genic enhancers	ES-UCSF4 Cell Line	embryonic stem cell
28	chr3:50284600-50287600	Genic enhancers	Primary hematopoietic stem cells short term culture	blood
29	chr3:50284600-50287800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr3:50284600-50288200	Genic enhancers	Fetal Thymus	thymus
31	chr3:50284600-50288600	Enhancers	Duodenum Mucosa	Duodenum
32	chr3:50284600-50289400	Genic enhancers	Primary T regulatory cells fromperipheralblood	blood
33	chr3:50284600-50294000	Genic enhancers	Placenta	Placenta
34	chr3:50284800-50288400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
35	chr3:50284800-50288400	Enhancers	Primary T helper naive cells from peripheral blood	blood
36	chr3:50284800-50288800	Enhancers	Liver	Liver
37	chr3:50284800-50289800	Genic enhancers	Primary T helper cells PMA-I stimulated	--
38	chr3:50284800-50291000	Weak transcription	HepG2	liver
39	chr3:50284800-50291200	Strong transcription	Cortex derived primary cultured neurospheres	brain
40	chr3:50284800-50293000	Genic enhancers	Primary Natural Killer cells fromperipheralblood	blood
41	chr3:50284800-50294000	Weak transcription	Fetal Kidney	kidney
42	chr3:50284800-50300600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
43	chr3:50285000-50287800	Weak transcription	H1 Cell Line	embryonic stem cell
44	chr3:50285000-50287800	Genic enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr3:50285000-50289000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
46	chr3:50285000-50290600	Genic enhancers	Primary T helper naive cells fromperipheralblood	blood
47	chr3:50285200-50288600	Weak transcription	HUES48 Cell Line	embryonic stem cell
48	chr3:50285200-50288600	Weak transcription	K562	blood
49	chr3:50285200-50289000	Genic enhancers	Colon Smooth Muscle	Colon
50	chr3:50285200-50290800	Genic enhancers	Primary neutrophils fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links